ELV - Elevance Health Inc.
Beaconlight Capital LLC bought a new position in shares of Elevance Health, Inc. (NYSE: ELV) in the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund bought 5,946 shares of the company's stock, valued at approximately $2,299,000. Elevance Health makes up about 0.8% of Beaconlight Capital LLC's
UNH outpaces ELV with stronger earnings prospects, improving Medicare profitability, greater upside and a more favorable risk-reward profile.
On August 25, 2026, we delve into the DCF analysis for Elevance Health Inc (ELV), a company that has shown impressive price performance recently, with a year-to
Barrow Hanley Mewhinney and Strauss LLC purchased a new stake in shares of Elevance Health, Inc. (NYSE: ELV) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 452,636 shares of the company's stock, valued at approximately $175,048,000. Barrow Hanley Mewhinney and
B. Metzler seel. Sohn and Co. AG purchased a new position in Elevance Health, Inc. (NYSE: ELV) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 31,408 shares of the company's stock, valued at approximately $12,146,000. Other institutional investors have also
Asahi Life Asset Management CO. LTD. purchased a new stake in Elevance Health, Inc. (NYSE: ELV) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 1,279 shares of the company's stock, valued at approximately $495,000. Several other large investors have also
Barden Capital Management Inc. acquired a new position in Elevance Health, Inc. (NYSE: ELV) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 1,609 shares of the company's stock, valued at approximately $622,000. A number of other institutional investors
Avise Financial Cooperative Inc. acquired a new stake in Elevance Health, Inc. (NYSE: ELV) in the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 1,633 shares of the company's stock, valued at approximately $632,000. A number of other hedge funds and other institutional investors
Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock?
Ballast Inc. acquired a new stake in Elevance Health, Inc. (NYSE: ELV) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 1,572 shares of the company's stock, valued at approximately $608,000. A number of other institutional investors and hedge funds
Axiom Investment Management LLC bought a new position in Elevance Health, Inc. (NYSE: ELV) during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 1,853 shares of the company's stock, valued at approximately $542,000. Other institutional investors have also recently
Bank of America Corp DE lifted its stake in Elevance Health, Inc. (NYSE: ELV) by 23.2% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,718,766 shares of the company's stock after buying an additional 511,626 shares during the period.
INDIANAPOLIS--(BUSINESS WIRE)--Cancer care is often overwhelming, not just medically, but emotionally and logistically. Elevance Health is strengthening its connected cancer care model to enhance support consumers receive throughout their care journeys, with a focus on earlier support, personalized care navigation, and more coordinated care.Each year in the U.S., 1.8 million people are diagnosed with cancer. For many patients, a cancer diagnosis brings not only medical decisions, but also a comp.
Delta Air Lines was a contributor during the quarter. Fuel prices spiked in March following the onset of the Iran War, creating a near-term headwind for airline profitability. Intercontinental Exchange stock price declined due to market concerns about AI disruption and potential competition from new exchanges launching perpetual futures. We were pleased to initiate a position in Equitable Holdings at a meaningful discount to intrinsic value.
Amundi increased its stake in shares of Elevance Health, Inc. (NYSE: ELV) by 145.7% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,693,664 shares of the company's stock after purchasing an additional 1,597,497 shares during the period. Amundi owned 1.24%
Tech stocks are dragging the Nasdaq lower while the Federal Reserve kicks off a critical policy meeting, and one major CEO just spent a million dollars buying into a stock the market punished after earnings.
Seth Klarman's Baupost Group rarely shows its cards, so when the latest 13F filing (holdings as of March 31, 2026, filed May 14, 2026) disclosed his five largest long common-stock positions, the disclosure read like a treasure map.
Bessemer Group Inc. lessened its stake in shares of Elevance Health, Inc. (NYSE: ELV) by 97.0% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,297 shares of the company's stock after selling 138,897 shares during the quarter. Bessemer Group Inc.'s
Shares of Elevance Health, Inc. (NYSE: ELV - Get Free Report) have been given an average recommendation of "Moderate Buy" by the twenty-three ratings firms that are covering the company, MarketBeat.com reports. Eight equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. The average
Acumen Wealth Advisors LLC decreased its stake in shares of Elevance Health, Inc. (NYSE: ELV) by 51.5% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,935 shares of the company's stock after selling 7,357 shares during the quarter. Acumen Wealth Advisors